WARMINSTER, Pa. (AP) — WARMINSTER, Pa. (AP) — Arbutus Biopharma Corp. (ABUS) on Wednesday reported a loss of $24.5 million in its first quarter. On a per-share basis, the Warminster ...

Perched on the edge of a cliff, overlooking Mount Vesuvius and the Bay of Naples, Sorrento’s location has ... get is a sense of theatre — and a menu that shows food can be fun and serious ...

Credit: Sorrento Sapori Facebook https://www.facebook.com/photo.php?fbid=900628198893190&set=pb.100068380530665.-2207520000&type=3 Switzerland’s IDAK Food Group ...

Arbutus is known for its annual Fourth of ... A few blocks from the barber shop, Sorrento restaurant — known for pizza and crab cakes — caters to UMBC students and faculty as well as blue ...

POLICE SHOOTING LASTED MUCH OF THE DAY IN ARBUTUS. A HEAVY PRESENCE OF BALTIMORE COUNTY POLICE OFFICERS AND DETECTIVES WORKING TO DETERMINE EXACTLY WHAT HAPPENED. ALONG WITH THE MARYLAND STATE ...

The Seattle-based brand gave us a preview of its upcoming menu this week, and there are a few favorites returning for another season alongside two entirely new summer menu items. This May ...

A lot has happened since I last put Arbutus Biopharma Corporation (NASDAQ:ABUS) in the spotlight early last summer. This clinical stage biopharma concern. Arbutus laid off approximately 40% of its ...

Arbutus Biopharma is cutting its workforce by more than half as it looks to improve its financial and operational efficiency. The clinical-stage biopharmaceutical company said its board approved a ...

Arbutus Biopharma is stripping back its workforce to just a “core team” needed to oversee mid-stage trials of the biotech's potential functional cure for hepatitis B. Lindsay Androski, who ...

Hotel Sorrento always seems to be working on ... This after earlier launching a slick Australian Cantonese restaurant, Shihuishi, in the pub’s basement. Now comes the next thing: a rooftop bar ...

Tourlite Capital Management highlighted stocks like Arbutus Biopharma Corporation (NASDAQ:ABUS), in the third quarter 2024 investor letter. Arbutus Biopharma Corporation (NASDAQ:ABUS) is a ...